SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lincoln Pharmaceuticals informs about press release

11 Aug 2023 Evaluate
Lincoln Pharmaceuticals has informed that it enclosed e-copies of newspaper publication with respect to the unaudited financial results (standalone & consolidated) of the company for the quarter ended on 30.06.2023.

The above information is a part of company’s filings submitted to BSE.

Lincoln Pharma Share Price

674.00 -26.75 (-3.82%)
12-May-2026 12:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1862.60
Dr. Reddys Lab 1279.30
Cipla 1298.60
Zydus Lifesciences 939.45
Lupin 2267.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×